Position in ACB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$61,954
-$406,502 QoQ
Shares Held
22,206
-71.7% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 149 holders
Holding Since
Jun 2021
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Jump Financial, LLC holds $51,184,372 across 18 Drug Manufacturers - Specialty & Generic names. ACB ranks #18 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
247,196 | $17,763,504 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
238,753 | $8,277,566 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
569,956 | $5,699,560 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
100,602 | $4,678,998 | |
| 5 | BHC |
Bausch Health Companies Inc.
|
611,100 | $3,012,723 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
70,430 | $2,889,742 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
42,773 | $1,548,382 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
104,200 | $1,509,858 |
All Filings in ACB
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,954 | 22,206 | Shares | Defined | 2026-08-13 | |
| 2025-09-30 | $468,456 | 78,600 | Shares | Defined | 2025-11-13 | |
| 2021-06-30 | $556,384 | 61,547 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||